Evidence map›Paper›PMID 42834055›Full record

ArticleNature communications2026

ProFormer: generalizable classification of single-cell and plasma proteomes using deep learning.

Karl K Krull, Arlene Kühn, Julia Höhn, Syed Azmal Ali, Martin H Otterbein, Titus J Brinker, Jeroen Krijgsveld

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karl K Krull *Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0009-0004-4377-9891
Arlene Kühn *Heidelberg University, Medical Faculty, Heidelberg, Germany.
Julia HöhnHeidelberg University, Medical Faculty, Heidelberg, Germany.
Syed Azmal AliProteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0003-3024-9379
Martin H OtterbeinProteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0009-0006-7832-3493
Titus J BrinkerDigitial Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany. titus.brinker@dkfz.de.ORCID 0000-0002-3620-5919
Jeroen KrijgsveldProteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. j.krijgsveld@dkfz.de.ORCID 0000-0001-7549-9326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteins are the main drivers of cell function and disease, making proteomics a powerful technique for biomarker discovery and defining cell identity. While current technologies can profile thousands of proteins and reach single-cell sensitivity, limited throughput restricts applications such as robust classification of large biological or clinical cohorts. To close this gap, we present a deep-learning (DL) approach for the direct analysis of mass spectrometric (MS) data, assigning proteomic profiles to sample identity. Specifically, we introduce the ProFormer, a transformer pipeline that classifies samples by tabular MS1-level features derived from peptide ions, eliminating the need for time-consuming data interpretation. The ProFormer outperforms traditional machine-learning and image-based convolutional neural networks (CNNs), demonstrating enhanced classification and generalization over 14 evaluated architectures. We further provide detailed insights into how the ProFormer dynamically aggregates MS1 data, while preserving signal contribution and enabling explainable AI at single-peptide resolution. Applied to diverse LC-MS data sets, the ProFormer accurately classified single-cell proteomes by cell type, cycle stage or differentiation trajectory, as well as patient disease status from plasma proteomes. Thereby, the ProFormer provides a versatile and rapid framework for the classification of proteomic data, with important implications for patient stratification, early detection and single-cell analysis.

Indexed as

Blood ProteinsDeep LearningProteomeProteomicsSingle-Cell AnalysisClassification AlgorithmsConvolutional Neural NetworksHumansLiquid Chromatography-Mass SpectrometryMass SpectrometryBlood ProteinsProteome

Identifiers

PMID42834055
PMCPMC13639084

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.